| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2017-02-15 | Signum Biosciences (USA - NJ) | $ 3 million | grant | National Institute of Allergy and Infectious Diseases (NIAID) (USA) | Dermatological diseases | Grant |
| 2017-02-15 | Fate Therapeutics (USA - CA) | $42.9 million | private placement | Cancer - Oncology - Immunological diseases | Private placement | |
| 2017-02-14 | Inventiva (France) | € 48 million | IPO | Fibrotic diseases - Hepatic diseases - Liver diseases | IPO | |
| 2017-02-13 | Emergent Biosolutions (USA - MD) | up to $30.5 million | grant | Biomedical Advanced Research and Development Authority (BARDA) (USA) | Grant | |
| 2017-02-10 | Santhera Pharmaceuticals (Switzerland) | CHF 60 million (€ 56.18 million) | private placement | Rare diseases - Genetic diseases - Hematological diseases | Private placement | |
| 2017-02-09 | Polyphor (Switzerland) | CHF 2.3 million (€ 2.15 million) | grant | Wellcome Trust (UK) | Infectious diseases | Grant |
| 2017-02-08 | Coherus Biosciences (USA - CA) | private placement | Private placement | |||
| 2017-02-08 | Acticor Biotech (France) | €2,9 million | financing round | Cap Decisif Management (France) | Cardiovascular diseases - Cerebrovascular diseases | Financing round |
| 2017-02-08 | Galena Biopharma (USA - OR) | private placement | Private placement | |||
| 2017-02-07 | Prexton Therapeutics (Switzerland) | € 29 million | series B financing round | Forbion Capital Partners (The Netherlands) Seroba Life Sciences (Ireland) Merck Ventures (The Netherlands) Ysios Capital (Spain) Sunstone Capital (Denmark) | Neurodegenerative diseases - CNS diseases | Series B financing round |
| 2017-02-07 | Lysogene (France) | € 22.6 million | IPO | Sofinnova Partners (France) BpiFrance (France) Novo A/S (Denmark) Financière Arbevel (France) Alto Invest (France) | Rare diseases - Genetic diseases | IPO |
| 2017-02-07 | OncoSNIPE® consortium (Oncodesign, Expert System, Sword, Acobiom, Hôpitaux Universitaires de Strasbourg, Centre George François Leclerc, Institut Paoli Calmettes) | €7.7 million | grant | Bpifrance (France) | Cancer - Oncology | Grant |
| 2017-02-01 | Confo Therapeutics (Belgium) | €2.57 million | grant | Flanders Innovation & Entrepreneurship (VLAIO) (Belgium) Innoviris (Belgium) | Fibrotic diseases | Grant |
| 2017-02-01 | MeiraGTx (USA - NY) | grant | Target ALS (USA) | Rare diseases - Neurodegenerative diseases | Grant | |
| 2017-02-01 | 20Med Therapeutics (NL) | €6 million | grant | European Commission’s Horizon 2020 programme | Neurodegenerative diseases | Grant |
| 2017-01-27 | PCI Biotech (Norway) | NOK 13.8 million | grant | the Research Council of Norway (Norway) | Cancer - Oncology | Grant |
| 2017-01-26 | Theradiag (France) PIoneer Project | €1.3 million | grant | European Eurostars Programme (EU) | Cancer - Oncology - Diagnostic | Subvention |
| 2017-01-25 | Sensorion (France) | €950,000 | loan | Bpifrance (France) Occitania region (France) | Otorhinolaryngology | Loan |
| 2017-01-20 | Affimed (Germany) | private placement | Cancer - Oncology | Private placement | ||
| 2017-01-20 | Stemline Therapeutics (USA - NY) | $45 million | private placement | Cancer - Oncology | Private placement |
